U.S. Software Stock News

Arena Group Holdings (AREN) has just posted its FY 2025 third quarter numbers, with revenue of US$29.8 million and basic EPS of US$0.14, while trailing twelve month revenue came in at US$142.8 million and EPS at US$0.64. Over recent quarters the company has seen revenue move between US$27.2 million and US$45.0 million per period, with basic EPS ranging from a loss of US$0.24 to a profit of US$0.26, and trailing twelve month net income excluding extra items reaching US$30.5 million. For...

Context for Masimo after recent share price moves Masimo (MASI) has been drawing investor attention after a strong month in the share price, with the stock closing at $175.97 and recent returns prompting closer scrutiny of its fundamentals. See our latest analysis for Masimo. Beyond the recent surge, Masimo’s share price return of 35.21% over the past 30 days and 29.66% over 90 days contrasts with a far more modest 4.64% one year total shareholder return. This suggests momentum has picked up...

HF Foods Group (HFFG) has just posted its FY 2025 third quarter numbers, with revenue at US$307 million and a basic EPS loss of US$0.02, while on a trailing 12 month basis revenue sits at about US$1.23 billion and basic EPS at a loss of US$0.86. The company has seen quarterly revenue move from US$302 million in Q2 FY 2024 to US$307 million in Q3 FY 2025, with basic EPS shifting across that period from roughly breakeven at US$0.00 in Q2 FY 2024 to a loss of US$0.02 in the latest quarter...

TrustCo Bank Corp NY (TRST) has rounded out FY 2025 with fourth quarter revenue of US$47.8 million and basic EPS of US$0.85, backed by trailing twelve month revenue of US$186.3 million and EPS of US$3.26. Over the past year, revenue has moved from US$169.8 million to US$186.3 million on a trailing basis, while basic EPS has shifted from US$2.57 to US$3.26. This sets the scene for investors to focus on how net profit margins at 32.8% and recent earnings growth shape the quality of this...

HUYA (NYSE:HUYA) has posted its latest FY 2025 numbers with Q3 revenue of C¥1.7b and basic EPS of C¥0.04, giving investors an opportunity to reassess the streaming platform's earnings path. The company reported revenue of C¥1.5b in Q1 2025, C¥1.6b in Q2 2025, and C¥1.7b in Q3 2025, while basic EPS moved from C¥0.00 in Q1 to a loss of C¥0.02 in Q2 before returning to a profit of C¥0.04 in Q3. This presents a mixed picture on margins but offers a clearer view of where profitability pressure...

Microvast Holdings (MVST) has posted its latest FY 2025 numbers with Q3 revenue at US$123.3 million, basic EPS at a loss of US$0.00 per share, and net income at a loss of US$1.5 million, while the trailing twelve months show revenue of US$444.5 million and a loss per share of US$0.40. The company has seen quarterly revenue range from US$83.7 million to US$123.3 million over the last six reported periods. Over the same period, basic EPS has swung between a profit of US$0.19 and losses of up to...

Prestige Consumer Healthcare recently appointed Horizon Media as its new media planning and buying agency after a four-month competitive review, aiming to enhance brand reach through data-driven audience targeting and optimized channel spending. This move signals Prestige’s push to sharpen its consumer insights and marketing efficiency, potentially reinforcing its position across key over-the-counter health categories. Next, we’ll examine how Horizon Media’s data-powered audience...

In recent years, Stride (NYSE: LRN), formerly K12, has delivered strong financial results, with annual revenue growing 14.6% over five years and earnings per share rising 45% annually over the past two years, significantly ahead of many peers. This sustained financial outperformance underscores Stride's growing presence in education technology and helps explain why investor attention has intensified around the company. We’ll now examine how Stride’s rapid earnings growth reshapes its...

Investors wondering if Golar LNG is still reasonably priced after a strong run, or if the easy gains are already behind it, can use this article to focus on what the current share price indicates about value. The stock recently closed at US$44.86, with returns of 3.3% over 30 days, 18.2% year to date and 31.0% over the last year. The past 3 years and 5 years show very large gains of 142.3% and 326.6% respectively. Recent coverage has centered on how Golar LNG is positioned within the energy...

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...

Tenet Healthcare recently reported fourth-quarter 2025 results that exceeded consensus expectations, supported by stronger same-facility revenues, a favorable payer mix, higher patient acuity, and contributions from Ambulatory Care acquisitions, while also updating its 2026 revenue and earnings outlook and progress on its multi-billion-dollar share repurchase program. Alongside these results, the company’s capital allocation signals were underscored by US$1.40 billion of share repurchases...

Earlier in 2026, Consumer365 named Coursera as a leading platform in its Best AI Course Online coverage, spotlighting the company’s broad catalogue of AI programs created with universities and technology partners. The recognition emphasizes Coursera’s role in practical, certificate-based AI learning that blends academic content with hands-on projects and assessments, reinforcing its positioning in professional upskilling. We’ll now examine how Consumer365’s endorsement of Coursera’s AI...

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...

In recent weeks, analysts have raised their earnings forecasts for Strategic Education and upgraded the stock to a Zacks Rank #1 (Strong Buy), signaling higher confidence in its expected financial performance. This broad-based improvement in earnings estimates suggests that analysts are reassessing the company’s underlying business trends rather than reacting to a single, one-off development. We’ll now examine how this stronger analyst earnings outlook may reshape Strategic Education’s...

Cognex recently reported a return to profitable growth, citing higher year-end factory automation spending, steady logistics demand, and authorizing an additional US$500 million share repurchase program alongside operational changes aimed at lowering costs. By pairing cost-cutting efforts with increased investment in AI-enabled machine vision, Cognex is signaling a focus on strengthening its competitive advantages rather than simply trimming expenses. Next, we’ll examine how the new US$500...

Federal Signal (FSS) is on investors’ radar after recent results showed year over year revenue growth, higher profitability, and a stronger free cash flow margin, all of which change the picture for its financial flexibility. See our latest analysis for Federal Signal. The share price has pulled back recently, with a 30 day share price return of an 11.25% decline and a 90 day share price return of a 3.89% decline. However, the 1 year total shareholder return of 37.16% and 5 year total...

EyePoint Pharmaceuticals reported fourth-quarter 2025 revenue of US$620,000 versus US$11.59 million a year earlier, with net loss widening to US$67.61 million and basic loss per share from continuing operations rising to US$0.81, while also granting long-term stock options and ending 2025 with cash reportedly sufficient to fund operations into late 2027. Despite weaker financial results, investor attention has shifted toward the CEO’s recent purchase of 1,500 shares, analyst optimism linked...

Garmin recently launched a premium 360-degree scanning sonar system with the motorized Spy Pole, offering anglers 2D and 3D, 360-degree underwater views, advanced GPS-integrated positioning, and wireless controls, with bundles priced around US$2,999.98 to US$3,199.98 and standalone Spy Pole units at US$1,999.99 to US$2,199.99. This new sonar and Spy Pole setup deepens Garmin’s presence in high-end Marine electronics by combining detailed underwater imaging with integrated, independent...

Critical Metals (NasdaqGM:CRML) has appointed international trade attorney Chang Oh Turkmani to its Advisory Board. Turkmani brings experience in global trade, commodity markets, and infrastructure development to support the Tanbreez rare earth project. The company highlights her role in cross border negotiations and supply chain planning as it advances its flagship Greenland asset. For investors tracking rare earth exposure, Critical Metals, listed as NasdaqGM:CRML, is positioning its...

DaVita (NYSE:DVA) is showing an unusual mix of signals, with a Strong Buy Quant Rating alongside distress-level Altman Z-Score readings. The company reports robust revenue growth and margin expansion while insiders have been selling shares in meaningful amounts. This combination of financial strength indicators and red flags has not been covered in recent discussions of DaVita. DaVita, a major provider of kidney care services, sits at the intersection of healthcare demand and reimbursement...

Wondering if QCR Holdings at around US$82.64 is offering value or asking too much at today's price? This breakdown will help you see what the current market is really pricing in. The stock has seen a 0.9% decline over the last 7 days and a 10.5% decline over the last 30 days, while returns sit at 0.6% year to date and 11.6% over the past year. This gives you a mixed set of signals to weigh. Recent news coverage has focused on QCR Holdings as a regional banking name that investors continue to...

Investor snapshot on Exponent Exponent (EXPO) has drawn fresh attention after recent share performance, with the stock down around 10% over the past 3 months and 18% over the past year. This has prompted investors to reassess its valuation. See our latest analysis for Exponent. With the share price at US$66.71, Exponent’s recent moves show pressure building rather than momentum, with a 7 day share price return of 7.19% and a 1 year total shareholder return of 18.33% pointing to weaker...

Payoneer Global (NasdaqGM:PAYO) has filed a shelf registration statement for a potential US$79 million offering tied to its Employee Stock Ownership Plan. The filing sets up the ability to issue or sell shares in connection with the ESOP over time, affecting how employee equity is managed. This move adds a fresh element to the Payoneer equity story beyond the recent focus on partnerships and valuation discussion. Payoneer operates a global payments and financial services platform that...

RenaissanceRe Holdings stock snapshot after recent performance moves RenaissanceRe Holdings (RNR) has drawn fresh attention after mixed share price moves, with a slight gain over the past day, a small decline over the past week and month, and a stronger rise over the past 3 months. See our latest analysis for RenaissanceRe Holdings. Looking beyond the latest move around the US$294 share price, RenaissanceRe Holdings shows momentum that has cooled in the very short term but remains positive...